QED Biomedical Ltd. provide Systematic & Rapid Reviews of data from early stage pre-clinical and biomedical studies
We are pioneering evidence based methods to combat low attrition rates, the reproducibility crisis, stealth research and publication bias
We can help you identify the risks in early biotechnology innovations; providing optimal decision making
We can assist with due diligence. Identifying the reproducibility and validity of new biomedical technologies
Areas of expertise
translational medicine, precision medicine, genomics, stem cell therapy, immunotherapy and gene therapy
We have particular expertise in preclinical models (human cell culture, organoids, 3D spheroids and patient derived xenografts), helping clients understand which are the best validated models for their needs
